Phibro Animal Health Corp (PAHC, Financial) is set to release its Q1 2025 earnings on Nov 7, 2024. The consensus estimate for Q1 2025 revenue is $244.40 million, and the earnings are expected to come in at $0.08 per share. The full year 2025's revenue is expected to be $1.21 billion and the earnings are expected to be $1.27 per share. More detailed estimate data can be found on the Forecast page.
Phibro Animal Health Corp (PAHC, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Phibro Animal Health Corp (PAHC) for the full year 2025 have increased from $1.13 billion to $1.21 billion. For 2026, revenue estimates have risen from $1.20 billion to $1.39 billion. Earnings estimates for the full year 2025 have also been revised upwards from $1.08 per share to $1.27 per share, and for 2026, from $1.52 per share to $1.82 per share.
Phibro Animal Health Corp (PAHC, Financial) Reported History
In the previous quarter of June 30, 2024, Phibro Animal Health Corp's (PAHC) actual revenue was $273.20 million, which beat analysts' revenue expectations of $263.25 million by 3.78%. Phibro Animal Health Corp's (PAHC) actual earnings were $0.02 per share, which missed analysts' earnings expectations of $0.30 per share by -93.22%. After releasing the results, Phibro Animal Health Corp (PAHC) was up by 3.17% in one day.
Phibro Animal Health Corp (PAHC, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 5 analysts, the average target price for Phibro Animal Health Corp (PAHC) is $16.80 with a high estimate of $22 and a low estimate of $9. The average target implies a downside of -26.48% from the current price of $22.85.
Based on GuruFocus estimates, the estimated GF Value for Phibro Animal Health Corp (PAHC, Financial) in one year is $20.52, suggesting a downside of -10.20% from the current price of $22.85.
Based on the consensus recommendation from 5 brokerage firms, Phibro Animal Health Corp's (PAHC, Financial) average brokerage recommendation is currently 3.6, indicating an "Underperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.